Triaksh Enterprises

Phosome 50mg, manufactured by Cipla Ltd., is a specialized antifungal medication containing Liposomal Amphotericin B. It belongs to the polyene class of antifungals and is reserved for treating severe, systemic, or life-threatening fungal infections such as invasive aspergillosis, candidiasis, and cryptococcal meningitis. Additionally, it is a primary treatment for Visceral Leishmaniasis (Kala-azar), a serious parasitic disease transmitted by sandflies.

The medication works through a fungicidal mechanism, meaning it actively kills the invading organisms rather than just inhibiting their growth. It targets ergosterol, a vital component of the fungal and parasitic cell membrane. By binding to ergosterol, Phosome creates pores in the cell wall, causing essential internal components to leak out, which ultimately leads to the death of the fungus or parasite. The "liposomal" delivery system is particularly significant as it allows the drug to be more selectively delivered to infected tissues while reducing toxicity to healthy cells, especially the kidneys.

Phosome is administered exclusively as an intravenous (IV) infusion by healthcare professionals in a hospital or clinic setting. It is never intended for self-administration. Because of the risk of serious allergic reactions, a small test dose is often given before starting the full treatment course.

6-MP 50mg is a chemotherapy medication manufactured by Zydus Cadila that contains the active ingredient Mercaptopurine. It belongs to a class of drugs known as purine antagonists or antimetabolites. It is mainly used to treat this type of blood cancer.

It works by interfering with the production of DNA and RNA, which prevents cancer cells from growing and multiplying.

It is often prescribed during the maintenance phase of cancer treatment.

Take the tablet whole with a glass of water. Do not crush, chew, or break it.

For best absorption, take it on an empty stomach, at least 1 hour before or 2 hours after a meal.

void taking it within 2 hours of consuming milk or dairy products, as they can interfere with its effectiveness.Take it at the same time every day to maintain steady levels in your body.

Lenangio 10 mg is an anti-cancer medication manufactured by Dr. Reddy's Laboratories Ltd. It contains the active ingredient Lenalidomide, which is classified as an immunomodulatory agent. This medication is primarily used to treat adult patients with various blood-related cancers, including multiple myeloma, mantle cell lymphoma, follicular lymphoma, and certain myelodysplastic syndromes (MDS) associated with chromosomal abnormalities.

The drug works through a multi-targeted mechanism. It modulates the immune system by activating T cells and Natural Killer (NK) cells to directly attack and kill cancer cells. Additionally, it possesses anti-angiogenic properties, meaning it inhibits the formation of new blood vessels that provide nutrients to tumours, thereby starving them and delaying their growth. It also directly interferes with the multiplication of abnormal cells in the bone marrow to encourage the production of healthy blood cells.

Acaone 100mg Capsule is an anticancer medicine containing the active constituent Acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase (BTK) inhibitors. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL).
The drug works by blocking the BTK protein, which is essential for the growth and survival of cancerous B-cells. By inhibiting this protein, it slows the spread and multiplication of cancer cells. Acaone 100mg Capsule is taken orally, preferably with food or between meals. It should be used in the dose and duration prescribed by your doctor. It is advised to take this medicine at a fixed time and for as long as the doctor prescribes to avoid missing a dose. It may take several weeks or months for you to see or feel the benefits.

Yondelis 1 mg Injection is an FDA-approved chemotherapy treatment used to manage soft tissue sarcoma and ovarian cancer. The active ingredient, Trabectedin, works by targeting and disrupting the DNA of cancer cells, preventing their growth and division. Administered via intravenous injection, this medication is often recommended for patients who have not responded to other treatments, offering an alternative for challenging cancers.

• Effective in treating soft tissue sarcomas and ovarian cancer
• Targeted therapy that directly interferes with cancer cell DNA
• Administered through IV injection, ensuring precise dosing
• Used when other therapies have failed or are not effective

• Trabectedin-based chemotherapy for resistant cancers
• Clinically proven to stop cancer cell growth
• FDA-approved for treating advanced cancers
• For adult patients under careful medical supervision

Yondelis is given through an intravenous (IV) infusion by a healthcare provider. It is typically used when standard treatments, like chemotherapy, have been unsuccessful. Regular monitoring during treatment is necessary to ensure safety and manage side effects.

Common side effects of Yondelis include nausea, fatigue, low blood counts, and immune suppression. Always consult your doctor to understand the full range of potential side effects and how to manage them effectively.

• What is Yondelis used for?
  Yondelis is used for the treatment of soft tissue sarcoma and ovarian cancer, particularly in cases resistant to other treatments.

• How is Yondelis administered?
  It is administered as an intravenous injection under the supervision of a healthcare professional.

• Are there any side effects?
  Common side effects include nausea, fatigue, and low blood counts. Your healthcare provider will monitor your progress throughout treatment.

For more details about Yondelis 1 mg Injection and its availability, please contact us today.